Is a complete ETR/IDD research report available?

No complete published report is available for etr/IDD (ETR/IDD) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

ETR/IDD (ETR/IDD)

Deutsche Börse Xetra: ETR/IDD · EUR

€1.51

+0.00 (0.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-29 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ETR/IDD analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	152.2M
Revenue (ttm)	9M
Net income (ttm)	-49.2M
EPS (ttm)	-€0.55
Volume	1,051

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 9M
Net income (ttm): -49.2M
EPS (ttm): -€0.55
Market cap: 152.2M

All ETR/IDD indicators

Market & fundamental data

Available fields

131

Groups with data

Currency

EUR

Showing 131 of 131 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	DE
Employees	164
Enterprise value	EUR 140.4M
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-07-22
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-07-29
Market cap	EUR 152.2M
Price	EUR 1.51
Price currency	EUR
Rev Per Employee	54,908.54x
Sic	2836
Symbol	etr/IDD
Website	https://www.innate-pharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-32.32%
EV/Sales	15.59x
FCF yield	-34.76%
P/B ratio	-7.01x
P/S ratio	16.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR -34.6M
Net Income	EUR -49.2M
Pretax Margin	-546.11%
Profit Per Employee	EUR -299,860
ROA	-38.85
Roa5y	-16.08
ROCE	-207.2
ROIC	-207.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue Growth	-55.25x
Revenue Growth Q	-46.7x
Revenue Growth3 Y	-46.15x
Revenue Growth5 Y	-33.05x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.1
Assets	EUR 62.7M
Cash	EUR 34.3M
Current Assets	EUR 46.7M
Current Liabilities	EUR 36.6M
Debt	EUR 22.6M
Debt FCF	EUR -0.43
Equity	EUR -21.7M
Interest Coverage	-122.7
Liabilities	EUR 84.4M
Long Term Assets	EUR 16M
Long Term Liabilities	EUR 47.8M
Net Cash	EUR 11.7M
Net Cash By Market Cap	EUR 7.71
Net Cash Growth	-76.42%
Tangible Book Value	EUR -21.7M
Tangible Book Value Per Share	EUR -0.23

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.27
Net Working Capital	EUR -15.4M
Quick ratio	1.14
Working Capital	EUR 10.1M
Working Capital Turnover	EUR 0.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	1.55
All Time High	2.1
All Time High Change	-28.1%
All Time High Date	2025-11-10
All Time Low	1.09
All Time Low Change	39.04%
All Time Low Date	2026-03-20
ATR	0.09
Ch YTD	-5.03
High	1.51
High52	2.1
High52 Date	2025-11-10
High52ch	-28.1%
Low	1.51
Low52	1.09
Low52 Date	2026-03-27
Low52ch	39.04%
Ma50ch	-2.83%
RSI	51.17
RSI Monthly	0
RSI Weekly	0
Sharpe ratio	-0.06x
Sortino ratio	-0.04
Total Return	-10.54%
Tr YTD	-5.03
Tr1m	-3.21%
Tr3m	6.04%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -54M
Operating margin	-599.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	70,666,485%
Net Borrowing	-8,911,000
Shares Insiders	0.74%
Shares Institutions	1.48%
Shares Qo Q	6.11%
Shares Yo Y	10.54%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -55.5M
Adjusted OCF	-55,322,000
Average Volume	1,837.55x
Bv Per Share	-0.23
CAPEX	EUR -140,000
Ch1m	-3.21
Ch3m	6.04
Ch6m	1.48
Change	0%
Change From Open	0
Close	0
Depreciation Amortization	700,000
Dollar Volume	1,587
Earnings Date	2026-09-17
EBIT	EUR -54M
EBITDA	EUR -53.3M
EPS	EUR -0.55
F Score	1
FCF	EUR -52.9M
FCF EV Yield	-37.67x
Financing CF	6,070,000
Fiscal Year End	December
Founded	1,999
Investing CF	7,289,000
Is Primary Listing	0
Last Earnings Date	2026-03-26
Last Report Date	2025-12-31
Ma20	1.4
Ma20ch	7.55%
Net CF	-38,304,000
Next Earnings Date	2026-09-17
Open	1.51
Ppne	4,356,000
Relative Volume	0.57x
Revenue	9,005,000x
SBC By Revenue	28.51x
Share Based Comp	2,567,000
Tr6m	1.48%
Volume	1,051
Z Score	-11.09

ETR/IDD (ETR/IDD)

Coverage state: Market snapshot only — no published research

Generate the first ETR/IDD analysis

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/IDD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/IDD indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ETR/IDD

Frequently asked questions